Tien Liang BioTech Co., Ltd. (TPEX:4127)
Taiwan · Delayed Price · Currency is TWD 74.00
-5.50 (-6.92%)
At close: Jul 9, 2026
Tien Liang BioTech Market Cap
Tien Liang BioTech has a market cap or net worth of 3.39 billion as of July 9, 2026. Its market cap has increased by 95.25% in one year.
Market Cap
3.39B
Enterprise Value
3.81B
Revenue
593.46M
Ranking
n/a
PE Ratio
533.69
Stock Price
74.00
Market Cap Chart
Since July 19, 2005, Tien Liang BioTech's market cap has increased from 767.70M to 3.39B, an increase of 341.09%. That is a compound annual growth rate of 7.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 3.39B | 138.71% |
| Dec 31, 2025 | 1.42B | -25.30% |
| Dec 31, 2024 | 1.90B | 186.21% |
| Dec 29, 2023 | 663.52M | -6.15% |
| Dec 30, 2022 | 706.99M | 4.39% |
| Dec 30, 2021 | 677.25M | 32.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SCI Pharmtech | 5.42B |
| LIWANLI Innovation | 5.13B |
| Easywell Biomedicals | 4.23B |
| Orient EuroPharma | 4.00B |
| Yoda Pharmaceuticals | 3.15B |
| Maywufa Company | 2.74B |
| Merdury Biopharmaceutical | 2.57B |
| PhytoHealth | 2.48B |